Pfizer Reports Earnings Tuesday. What to Anticipate.
Textual content sizing Analysts count on Pfizer’s Covid-19 vaccine product sales to drop to $14.2 billion in 2023 from an ...
Read moreDetails
Tag: JNJ
J&J Can’t Use Bankruptcy to Take care of Talc-Damage Lawsuits, Appeals Court docket Guidelines
A federal appeals court docket turned down Johnson & Johnson ‘s plan to use a lawful method to force about ...
Read moreDetails
J&J Will get Ready to Split Up With Tylenol
J&J Gets Prepared to Split Up With Tylenol
Read moreDetails
Johnson & Johnson Guides Over Expectations for 2023
Text sizing Johnson & Johnson’s direction for 2023 came in better than sector anticipations. Mark Ralston/AFP through Getty Visuals Johnson ...
Read moreDetails
GE, Microsoft, J&J, Lyft, and More Inventory Sector Movers
Textual content measurement Typical Electric powered is scheduled to report fourth-quarter earnings Tuesday. Loic Venance/AFP by way of Getty Photos ...
Read moreDetails
J&J Experiences Earnings Tuesday. What to Hope.
Textual content size Prescription drugs large Johnson & Johnson will report fourth-quarter and total-yr earnings early Tuesday. Mark Ralston/AFP by ...
Read moreDetails
Tesla, AT&T, Visa, Chevron, Microsoft, and More Stocks for Investors to Watch This Week
Text size It will be a big week of fourth-quarter earnings, with about 90 S&P 500 companies scheduled to report. ...
Read moreDetails
Tanking Biotech Stocks Will Imply a Large Year for Offers. Who Could Advantage.
Virtually two years following biotechnology shares began to tumble, executives at modest and midsize corporations in the room are lastly ...
Read moreDetails
GE’s Spinoff Deserves Balanced Skepticism
GE’s Spinoff Warrants Healthy Skepticism
Read moreDetails
Why Pfizer Is Pulling Back again on Exploration Into Unusual Condition, Gene Treatment
Pfizer is preparing to pull again on early-phase research into treatments for exceptional illnesses, which include the development of new ...
Read moreDetails